tumor

September 19, 2025

An epigenetic algorithm traces the origin of cancer and predicts its progression

A scientific team led by Clínic-IDIBAPS (Barcelona) and the Institute of Cancer Research (London) has developed an innovative method based on DNA methylation to decipher the origin and evolution of cancer.
September 11, 2025

Alejandra González, the biologist with the key to curing pancreatic cancer: "It could be applied to more tumors."

The proposal by the scientist from the Aragón Health Research Institute (IIS Aragón) was recognized a few months ago by L'Oréal-UNESCO 'For Women in Science'.
8 May 2025

Aspanoa invests 120.000 euros to promote new immunotherapies for childhood cancer.

It will be distributed equally between two research projects. One is led by Diego Sánchez (IIS Aragón) and the other by Eva Gálvez (CSIC) and Ramón Hurtado (BIFI – Unizar). Immunotherapy is a treatment already being applied to some cancer patients, including children, when standard therapies are insufficient.
25 February, 2025

Researchers from IIS Aragón and I3A create a microfluidic device to better understand the communication between a brain tumor and the immune system

The TME Lab research group has developed the new device that allows studying the interaction between tumor and immune cells. The scientific journal Nano-Micro Small has published the research.
November 19, 2024

Dolores Isla, IP of the IIS Aragón: “Spain is a leader in participation in clinical trials for lung cancer”

On the occasion of World Lung Cancer Day, ConSalud.es interviews Dr. Dolores Isla, IP of the Medical Oncology group at the Lozano Blesa Clinical Hospital (GIIS025) of the IIS Aragón and president of the Association for Lung Cancer Research in Women.
September 17, 2024

On the trail of new biomarkers to detect glioblastoma and colorectal cancer

A new study by the IIS Aragón and the Aragón Engineering Research Institute, published by the Scientific Society of Biofabrication, recreates tumors in 3D models and analytical chemistry techniques to open new, less invasive diagnostic pathways that improve patient prognosis.